BioNTech SE (Nasdaq: BNTX, “BioNTech”) has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution.
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
February 16, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022